Thermo-Controlled in Situ Phase Transition of Polymer–Peptides on Cell Surfaces for High-Performance Proliferative Inhibition
Source abstract
Abstract
We herein report a thermocontrolled strategy for realizing in situ conformational transition of polymer-peptide conjugates at cell surfaces to manipulate and monitor HER2 receptor clustering, which finally result in effective breast cancer cell proliferation inhibition. Functional paring motifs (HBP) are covalently linked to a synthetic thermoresponsive polymer PNIPAAm to incorporate temperature control properties to HER2 targeting peptide. At 40 °C, the PNIPAAm polymers collapse and act as a "shield" to block the aggregation of HBP. Upon cooling to 35 °C, polymers are in their extended state and HBP are expose in aqueous and aggregate subsequently with enhanced fluorescence, allowing for promoting and in situ monitoring of receptor clustering. Ultimately, HER2 receptor clustering leads to cytoplasmic domain phosphorylation, which further results in effective cancer cell proliferation inhibition. We envision that this useful approach has the potential to be applied for molecule-targeted tumor therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Chemical Synthesis and Analysis · Polymer Surface Interaction Studies · Peptidase Inhibition and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, P. R. China
University of Chinese Academy of Science (UCAS), No. 19A Yuquan Road, Beijing, 100049, P. R. China
Funding
Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Beijing Municipal Science and Technology
References (31)
Show source-provided references
1. 10.1038/ncomms171410.1038/ncomms1714 ↗
2. 10.1038/ncomms204010.1038/ncomms2040 ↗
3. 10.1038/nmat343010.1038/nmat3430 ↗
4. 10.1038/ncomms505710.1038/ncomms5057 ↗
5. 10.1002/adma.20130120210.1002/adma.201301202 ↗
6. 10.1021/ja513034e10.1021/ja513034e ↗
7. 10.1039/C5TB00347D10.1039/C5TB00347D ↗
8. 10.1002/anie.20130338710.1002/anie.201303387 ↗
9. 10.1039/C4CC07533A10.1039/C4CC07533A ↗
10. 10.1002/adma.20150180310.1002/adma.201501803 ↗
11. 10.1002/anie.20090512610.1002/anie.200905126 ↗
12. 10.1002/adma.20150259810.1002/adma.201502598 ↗
13. 10.1002/adfm.20140319010.1002/adfm.201403190 ↗
14. 10.1016/j.biomaterials.2013.12.01810.1016/j.biomaterials.2013.12.018 ↗
15. 10.1002/adfm.20150204910.1002/adfm.201502049 ↗
16. 10.1016/j.jconrel.2016.05.01410.1016/j.jconrel.2016.05.014 ↗
17. 10.1038/nchem.157310.1038/nchem.1573 ↗
18. 10.1039/C5PY00497G10.1039/C5PY00497G ↗
19. 10.1021/ja412735p10.1021/ja412735p ↗
20. 10.1021/bm500532x10.1021/bm500532x ↗
21. 10.1021/acsami.5b0402510.1021/acsami.5b04025 ↗
22. 10.1002/anie.20140073510.1002/anie.201400735 ↗
23. 10.1016/j.cell.2010.06.01110.1016/j.cell.2010.06.011 ↗
24. 10.1002/ange.20130786910.1002/ange.201307869 ↗
25. 10.1038/sj.onc.121052810.1038/sj.onc.1210528 ↗
26. 10.1021/jp409557g10.1021/jp409557g ↗
27. 10.1021/cr400166n10.1021/cr400166n ↗
28. 10.1016/j.ejpb.2013.03.02310.1016/j.ejpb.2013.03.023 ↗
29. 10.1016/j.polymer.2013.06.04510.1016/j.polymer.2013.06.045 ↗
30. 10.1016/j.biomaterials.2006.05.01610.1016/j.biomaterials.2006.05.016 ↗
31. 10.1073/pnas.071216810510.1073/pnas.0712168105 ↗